RHUMBLINE ADVISERS

Position in NMRA — Neumora Therapeutics, Inc.

CIK 1115418 BOSTON, MA

Position in NMRA

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$131,862

+$126,830 QoQ

Shares Held

77,566

+2905.3% QoQ

Ownership

0.041%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#61

of 111 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 31% Shared 0% None 69%

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,404,721,264 across 329 Biotechnology names. NMRA ranks #265 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	396,380	$196,893,837
2	REGN	Regeneron Pharmaceuticals, Inc.	157,794	$98,390,870
3	MRNA	Moderna, Inc.	809,853	$56,714,005
4	ALNY	Alnylam Pharmaceuticals, Inc.	165,579	$49,844,246
5	INCY	Incyte Corp	428,533	$48,578,500
6	RVMD	Revolution Medicines, Inc.	226,008	$42,326,778
7	ROIV	Roivant Sciences Ltd.	1,178,789	$41,717,342
8	JAZZ	Jazz Pharmaceuticals plc	163,018	$39,282,447

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$131,862	77,566	+2905.3%	Shares	Sole	2026-08-12
2026-03-31	$5,032	2,581	0.0%	Shares	Sole	2026-05-12
2025-12-31	$4,619	2,581	0.0%	Shares	Sole	2026-02-13
2025-09-30	$4,697	2,581	0.0%	Shares	Sole	2025-11-06
2025-06-30	$1,891	2,581	-97.7%	Shares	Sole	2025-08-12
2025-03-31	$114,458	114,458	+1.5%	Shares	Sole	2025-05-29
2024-12-31	$1,195,044	112,740	+1.0%	Shares	Sole	2025-05-29
2024-09-30	$1,475,094	111,665	+8.1%	Shares	Sole	2024-11-12
2024-06-30	$1,015,026	103,258	+488.3%	Shares	Sole	2024-08-01
2024-03-31	$241,340	17,552	+11.7%	Shares	Sole	2024-05-09
2023-12-31	$268,026	15,720	—	Shares	Sole	2024-02-08
No filing history on record for this holder in this stock.